Research and Evaluation of the Allosteric Protein-Specific Force Field Based on a Pre-Training Deep Learning Model

Allosteric modulators are important regulation elements that bind the allosteric site beyond the active site, leading to the changes in dynamic and/or thermodynamic properties of the protein. Allosteric modulators have been a considerable interest as potential drugs with high selectivity and safety. However, current experimental methods have limitations to identify allosteric sites. Therefore, molecular dynamics simulation based on empirical force field becomes an important complement of experimental methods. Moreover, the precision and efficiency of current force fields need improvement. Deep learning and reweighting methods were used to train allosteric protein-specific precise force field (named APSF). Multiple allosteric proteins were used to evaluate the performance of APSF. The results indicate that APSF can capture different types of allosteric pockets and sample multiple energy-minimum reference conformations of allosteric proteins. At the same time, the efficiency of conformation sampling for APSF is higher than that for ff14SB. These findings confirm that the newly developed force field APSF can be effectively used to identify the allosteric pocket that can be further used to screen potential allosteric drugs based on these pockets.

[1]  A. Rehman,et al.  Phosphorylation Modification Force Field FB18CMAP Improving Conformation Sampling of Phosphoproteins , 2023, J. Chem. Inf. Model..

[2]  Haifeng Chen,et al.  Personal Precise Force Field for Intrinsically Disordered and Ordered Proteins Based on Deep Learning , 2022, J. Chem. Inf. Model..

[3]  Haifeng Chen,et al.  Base-specific RNA force field improving the dynamics conformation of nucleotide. , 2022, International journal of biological macromolecules.

[4]  V. Casadó,et al.  Unmasking allosteric-binding sites: novel targets for GPCR drug discovery , 2022, Expert opinion on drug discovery.

[5]  C. Lyssiotis,et al.  Targeting allosteric regulation of cancer metabolism , 2022, Nature Chemical Biology.

[6]  M. P. Dillon,et al.  Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies. , 2022, Journal of medicinal chemistry.

[7]  N. Dokholyan,et al.  Design and engineering of allosteric communications in proteins. , 2022, Current opinion in structural biology.

[8]  Shaoyong Lu,et al.  Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery. , 2021, Journal of medicinal chemistry.

[9]  Junhong Lü,et al.  Molecular Dynamics-Based Allosteric Prediction Method to Design Key Residues in Threonine Dehydrogenase for Amino-Acid Production , 2021, ACS omega.

[10]  Y. Fukunishi,et al.  Molecular Dynamics Simulation Study on Allosteric Regulation of CD44-Hyaluronan Binding as a Force Sensing Mechanism , 2021, ACS omega.

[11]  Ray Luo,et al.  Recent Force Field Strategies for Intrinsically Disordered Proteins , 2021, J. Chem. Inf. Model..

[12]  J. Bajorath,et al.  Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds. , 2021, Journal of medicinal chemistry.

[13]  Jonathan P. Mailoa,et al.  E(3)-equivariant graph neural networks for data-efficient and accurate interatomic potentials , 2021, Nature Communications.

[14]  P. Hamm,et al.  Sensing the allosteric force , 2020, Nature Communications.

[15]  Ashfaq Ur Rehman,et al.  Comparison and Evaluation of Force Fields for Intrinsically Disordered Proteins , 2020, J. Chem. Inf. Model..

[16]  Ray Luo,et al.  Environment-Specific Force Field for Intrinsically Disordered and Ordered Proteins , 2020, J. Chem. Inf. Model..

[17]  Shaoyong Lu,et al.  Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance. , 2020, Trends in pharmacological sciences.

[18]  Shaoyong Lu,et al.  Unraveling allosteric landscapes of allosterome with ASD , 2019, Nucleic Acids Res..

[19]  R. Luo,et al.  A Well-Balanced Force Field ff03CMAP for Folded and Disordered Proteins. , 2019, Journal of chemical theory and computation.

[20]  Sheng Yang,et al.  Residue-Specific Force Field Improving the Sample of Intrinsically Disordered Proteins and Folded Proteins , 2019, J. Chem. Inf. Model..

[21]  J. Desai,et al.  The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , 2019, Nature.

[22]  Gennady M Verkhivker,et al.  Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications. , 2019, Journal of chemical theory and computation.

[23]  B. Stockwell,et al.  K-RasG12D Has a Potential Allosteric Small Molecule Binding Site. , 2019, Biochemistry.

[24]  Daniel W. A. Buchan,et al.  The PSIPRED Protein Analysis Workbench: 20 years on , 2019, Nucleic Acids Res..

[25]  Shaoyong Lu,et al.  Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. , 2019, Journal of medicinal chemistry.

[26]  Amit K. Gupta,et al.  Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding , 2019, ACS omega.

[27]  Jaswinder Singh,et al.  Single‐sequence‐based prediction of protein secondary structures and solvent accessibility by deep whole‐sequence learning , 2018, J. Comput. Chem..

[28]  R. Luo,et al.  Intrinsically disordered protein‐specific force field CHARMM36IDPSFF , 2018, Chemical biology & drug design.

[29]  C. Yun,et al.  Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045. , 2018, Biochemical and biophysical research communications.

[30]  Joe G. Greener,et al.  High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery , 2018, Angewandte Chemie (International Ed. in English).

[31]  Shaoyong Lu,et al.  Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions. , 2018, Journal of medicinal chemistry.

[32]  Dong Song,et al.  The IDP-Specific Force Field ff14IDPSFF Improves the Conformer Sampling of Intrinsically Disordered Proteins , 2017, J. Chem. Inf. Model..

[33]  John Hardy,et al.  An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks , 2017, BMC Systems Biology.

[34]  Lingxin Zhang,et al.  Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation. , 2017, The Journal of chemical physics.

[35]  Ray Luo,et al.  ff14IDPs force field improving the conformation sampling of intrinsically disordered proteins , 2017, Chemical biology & drug design.

[36]  B. L. de Groot,et al.  CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.

[37]  Ruth Nussinov,et al.  Introduction to Protein Ensembles and Allostery. , 2016, Chemical reviews.

[38]  Karl R. Weiss,et al.  A survey of transfer learning , 2016, Journal of Big Data.

[39]  W. M. Hewitt,et al.  Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9. , 2016, Angewandte Chemie.

[40]  Haikuo Zhang,et al.  Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors , 2016 .

[41]  Lazaros Mavridis,et al.  A Random Forest Model for Predicting Allosteric and Functional Sites on Proteins , 2016, Molecular informatics.

[42]  Moroni,et al.  Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands , 2016, Scientific Reports.

[43]  R. Nussinov,et al.  The Role of Protein Loops and Linkers in Conformational Dynamics and Allostery. , 2016, Chemical reviews.

[44]  Huan‐Xiang Zhou,et al.  Protein Allostery and Conformational Dynamics. , 2016, Chemical reviews.

[45]  A. Azab,et al.  MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma , 2016, Blood Cancer Journal.

[46]  Julian Frank,et al.  Methods to test for equality of two normal distributions , 2016, Stat. Methods Appl..

[47]  André A. S. T. Ribeiro,et al.  A Chemical Perspective on Allostery. , 2016, Chemical reviews.

[48]  Susan S. Taylor,et al.  Dynamics-Driven Allostery in Protein Kinases. , 2015, Trends in biochemical sciences.

[49]  Shuai Li,et al.  ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks , 2015, Nucleic Acids Res..

[50]  M. Clausen,et al.  FDA-approved small-molecule kinase inhibitors. , 2015, Trends in pharmacological sciences.

[51]  Wei Wang,et al.  Test and Evaluation of ff99IDPs Force Field for Intrinsically Disordered Proteins , 2015, J. Chem. Inf. Model..

[52]  Ruth Nussinov,et al.  Principles of Allosteric Interactions in Cell Signaling , 2014, Journal of the American Chemical Society.

[53]  Shaoyong Lu,et al.  Harnessing Allostery: A Novel Approach to Drug Discovery , 2014, Medicinal research reviews.

[54]  Rommie E. Amaro,et al.  POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics , 2014, Journal of chemical theory and computation.

[55]  Ray Luo,et al.  New Force Field on Modeling Intrinsically Disordered Proteins , 2014, Chemical biology & drug design.

[56]  Shuai Li,et al.  ASD v2.0: updated content and novel features focusing on allosteric regulation , 2013, Nucleic Acids Res..

[57]  Yu Luo,et al.  Allosite: a method for predicting allosteric sites , 2013, Bioinform..

[58]  R. Nussinov,et al.  Allostery in Disease and in Drug Discovery , 2013, Cell.

[59]  P. Alzari,et al.  Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site. , 2012, Chemistry & biology.

[60]  L. Lai,et al.  Identifying Allosteric Binding Sites in Proteins with a Two-State Go̅ Model for Novel Allosteric Effector Discovery. , 2012, Journal of chemical theory and computation.

[61]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[62]  R. Nussinov,et al.  Dynamic allostery: linkers are not merely flexible. , 2011, Structure.

[63]  Huijong Han,et al.  Discovery of a potential allosteric ligand binding site in CDK2. , 2011, ACS chemical biology.

[64]  Geng Wu,et al.  ASD: a comprehensive database of allosteric proteins and modulators , 2010, Nucleic Acids Res..

[65]  Stanislas Leibler,et al.  An interdomain sector mediating allostery in Hsp70 molecular chaperones , 2010, Molecular systems biology.

[66]  Vincent Le Guilloux,et al.  Fpocket: An open source platform for ligand pocket detection , 2009, BMC Bioinformatics.

[67]  M. V. Tretyakov,et al.  Langevin thermostat for rigid body dynamics. , 2009, The Journal of chemical physics.

[68]  N. Goodey,et al.  Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.

[69]  Greg L. Hura,et al.  Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew. , 2004, The Journal of chemical physics.

[70]  James R Horn,et al.  Allosteric inhibition through core disruption. , 2004, Journal of molecular biology.

[71]  S. Hochreiter,et al.  Long Short-Term Memory , 1997, Neural Computation.

[72]  Kuldip K. Paliwal,et al.  Bidirectional recurrent neural networks , 1997, IEEE Trans. Signal Process..

[73]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[74]  Hermann Schindelin,et al.  Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein , 1993, Nature.

[75]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[76]  M. Karplus,et al.  Dynamics of folded proteins , 1977, Nature.

[77]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[78]  Shaoyong Lu,et al.  Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery. , 2019, Drug discovery today.